Valine 50mg/ml and Isoleucine 25mg/ml Oral Solutions for Maple Syrup Urine Disease (MSUD) - Acceptability and Tolerance Study
This is a prospective, observational research study in 5 children with Maple Syrup Urine Disease (MSUD). Subjects who are currently taking a valine and isoleucine supplement for MSUD will be recruited for a 56 day trial, of a new ready-to-use valine supplement and a new ready-to-use isoleucine supplement, to evaluate the tolerability and acceptability of the study products compared with their usual products.
100 项与 Meta Healthcare Pvt. Ltd. 相关的临床结果
0 项与 Meta Healthcare Pvt. Ltd. 相关的专利(医药)
100 项与 Meta Healthcare Pvt. Ltd. 相关的药物交易
100 项与 Meta Healthcare Pvt. Ltd. 相关的转化医学